Item 7.01. Regulation FD Disclosure.

The information in this Current Report (including Exhibits 99.1 and 99.2) is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Current Report (including Exhibits 99.1 and 99.2) shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

Members of the Theravance Biopharma, Inc. management team will be presenting at the 39th Annual J.P. Morgan Healthcare Conference on January 13, 2021 and from January 11-14, 2021 conducting one-on-one meetings with analysts and investors during the conference using a slide presentation which is being furnished pursuant to Regulation FD as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. Additionally, a copy of an Appendix of additional materials is furnished as Exhibit 99.2 to this Current Report and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.






(d) Exhibits.

    99.1        Slide deck entitled JP Morgan Healthcare Conference

    99.2        Slide deck entitled JP Morgan 2021 Appendix

     104      Cover Page Interactive Data File (cover page XBRL tags embedded within
              the Inline XBRL document)

© Edgar Online, source Glimpses